Peter G. Traber, President and CEO at GALECTIN THERAPEUTICS INC (GALT), bought 1,000 shares at $5.80 ($6K) on 2013-11-18, disclosed to the SEC on 2013-11-19.
Open-market purchase of $6k GALT by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| SELB | SELL | 2022-01-07 | $10K | — | Filing → |
| SELB | SELL | 2021-12-14 | $12K | — | Filing → |
| SELB | SELL | 2021-10-15 | $16K | — | Filing → |